Global and United States Human Rotavirus Vaccine Market Insights, Forecast to 2026

Global and United States Human Rotavirus Vaccine Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Human Rotavirus Vaccine Product Introduction
1.2 Market Segments
1.3 Key Human Rotavirus Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human Rotavirus Vaccine Market Size Growth Rate by Type
1.4.2 Rotarix
1.4.3 RotaTeq
1.4.4 Rotavac
1.4.5 Rotavin-M1
1.4.6 Lanzhou lamb
1.4.7 Others
1.5 Market by Application
1.5.1 Global Human Rotavirus Vaccine Market Size Growth Rate by Application
1.5.2 Hospitals & Clinics
1.5.3 Academic And Research
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human Rotavirus Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Human Rotavirus Vaccine Revenue 2015-2026
2.1.2 Global Human Rotavirus Vaccine Sales 2015-2026
2.2 Global Human Rotavirus Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Human Rotavirus Vaccine Historical Market Size by Region (2015-2020)
2.3.1 Global Human Rotavirus Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Human Rotavirus Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Human Rotavirus Vaccine Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Human Rotavirus Vaccine Sales Forecast by Region (2021-2026)
2.4.2 Global Human Rotavirus Vaccine Revenue Forecast by Region (2021-2026)
3 Global Human Rotavirus Vaccine Competitor Landscape by Players
3.1 Global Top Human Rotavirus Vaccine Sales by Manufacturers
3.1.1 Global Human Rotavirus Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Global Human Rotavirus Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Global Human Rotavirus Vaccine Manufacturers by Revenue
3.2.1 Global Human Rotavirus Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Global Human Rotavirus Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Rotavirus Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Rotavirus Vaccine Revenue in 2019
3.2.5 Global Human Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Human Rotavirus Vaccine Price by Manufacturers
3.4 Global Human Rotavirus Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Human Rotavirus Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Rotavirus Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Human Rotavirus Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Human Rotavirus Vaccine Market Size by Type (2015-2020)
4.1.1 Global Human Rotavirus Vaccine Sales by Type (2015-2020)
4.1.2 Global Human Rotavirus Vaccine Revenue by Type (2015-2020)
4.1.3 Human Rotavirus Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human Rotavirus Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Human Rotavirus Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Human Rotavirus Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Human Rotavirus Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human Rotavirus Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Human Rotavirus Vaccine Market Size by Application (2015-2020)
5.1.1 Global Human Rotavirus Vaccine Sales by Application (2015-2020)
5.1.2 Global Human Rotavirus Vaccine Revenue by Application (2015-2020)
5.1.3 Human Rotavirus Vaccine Price by Application (2015-2020)
5.2 Human Rotavirus Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Human Rotavirus Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Human Rotavirus Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Rotavirus Vaccine Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Human Rotavirus Vaccine Market Size YoY Growth 2015-2026
6.1.1 United States Human Rotavirus Vaccine Sales YoY Growth 2015-2026
6.1.2 United States Human Rotavirus Vaccine Revenue YoY Growth 2015-2026
6.1.3 United States Human Rotavirus Vaccine Market Share in Global Market 2015-2026
6.2 United States Human Rotavirus Vaccine Market Size by Players (International and Local Players)
6.2.1 United States Top Human Rotavirus Vaccine Players by Sales (2015-2020)
6.2.2 United States Top Human Rotavirus Vaccine Players by Revenue (2015-2020)
6.3 United States Human Rotavirus Vaccine Historic Market Review by Type (2015-2020)
6.3.1 United States Human Rotavirus Vaccine Sales Market Share by Type (2015-2020)
6.3.2 United States Human Rotavirus Vaccine Revenue Market Share by Type (2015-2020)
6.3.3 United States Human Rotavirus Vaccine Price by Type (2015-2020)
6.4 United States Human Rotavirus Vaccine Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Human Rotavirus Vaccine Sales Forecast by Type (2021-2026)
6.4.2 United States Human Rotavirus Vaccine Revenue Forecast by Type (2021-2026)
6.4.3 United States Human Rotavirus Vaccine Price Forecast by Type (2021-2026)
6.5 United States Human Rotavirus Vaccine Historic Market Review by Application (2015-2020)
6.5.1 United States Human Rotavirus Vaccine Sales Market Share by Application (2015-2020)
6.5.2 United States Human Rotavirus Vaccine Revenue Market Share by Application (2015-2020)
6.5.3 United States Human Rotavirus Vaccine Price by Application (2015-2020)
6.6 United States Human Rotavirus Vaccine Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Human Rotavirus Vaccine Sales Forecast by Application (2021-2026)
6.6.2 United States Human Rotavirus Vaccine Revenue Forecast by Application (2021-2026)
6.6.3 United States Human Rotavirus Vaccine Price Forecast by Application (2021-2026)
7 North America
7.1 North America Human Rotavirus Vaccine Market Size YoY Growth 2015-2026
7.2 North America Human Rotavirus Vaccine Market Facts & Figures by Country
7.2.1 North America Human Rotavirus Vaccine Sales by Country (2015-2020)
7.2.2 North America Human Rotavirus Vaccine Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Human Rotavirus Vaccine Market Size YoY Growth 2015-2026
8.2 Europe Human Rotavirus Vaccine Market Facts & Figures by Country
8.2.1 Europe Human Rotavirus Vaccine Sales by Country
8.2.2 Europe Human Rotavirus Vaccine Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Human Rotavirus Vaccine Market Size YoY Growth 2015-2026
9.2 Asia Pacific Human Rotavirus Vaccine Market Facts & Figures by Country
9.2.1 Asia Pacific Human Rotavirus Vaccine Sales by Region (2015-2020)
9.2.2 Asia Pacific Human Rotavirus Vaccine Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Human Rotavirus Vaccine Market Size YoY Growth 2015-2026
10.2 Latin America Human Rotavirus Vaccine Market Facts & Figures by Country
10.2.1 Latin America Human Rotavirus Vaccine Sales by Country
10.2.2 Latin America Human Rotavirus Vaccine Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Human Rotavirus Vaccine Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Human Rotavirus Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Human Rotavirus Vaccine Sales by Country
11.2.2 Middle East and Africa Human Rotavirus Vaccine Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Bharat Biotech
12.1.1 Bharat Biotech Corporation Information
12.1.2 Bharat Biotech Description and Business Overview
12.1.3 Bharat Biotech Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bharat Biotech Human Rotavirus Vaccine Products Offered
12.1.5 Bharat Biotech Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Description and Business Overview
12.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Human Rotavirus Vaccine Products Offered
12.2.5 Merck Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Corporation Information
12.3.2 GlaxoSmithKline Description and Business Overview
12.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GlaxoSmithKline Human Rotavirus Vaccine Products Offered
12.3.5 GlaxoSmithKline Recent Development
12.11 Bharat Biotech
12.11.1 Bharat Biotech Corporation Information
12.11.2 Bharat Biotech Description and Business Overview
12.11.3 Bharat Biotech Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Bharat Biotech Human Rotavirus Vaccine Products Offered
12.11.5 Bharat Biotech Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Human Rotavirus Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Rotavirus Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Human Rotavirus Vaccine Market Segments
Table 2. Ranking of Global Top Human Rotavirus Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Rotavirus Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Rotarix
Table 5. Major Manufacturers of RotaTeq
Table 6. Major Manufacturers of Rotavac
Table 7. Major Manufacturers of Rotavin-M1
Table 8. Major Manufacturers of Lanzhou lamb
Table 9. Major Manufacturers of Others
Table 10. Global Human Rotavirus Vaccine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global Human Rotavirus Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global Human Rotavirus Vaccine Sales by Regions 2015-2020 (K Units)
Table 13. Global Human Rotavirus Vaccine Sales Market Share by Regions (2015-2020)
Table 14. Global Human Rotavirus Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Human Rotavirus Vaccine Sales Forecast by Region (2021-2026) (K Units)
Table 16. Global Human Rotavirus Vaccine Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Human Rotavirus Vaccine Sales Share by Manufacturers (2015-2020)
Table 18. Global Human Rotavirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Human Rotavirus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Rotavirus Vaccine as of 2019)
Table 20. Human Rotavirus Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Human Rotavirus Vaccine Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Human Rotavirus Vaccine Price (2015-2020) (USD/Unit)
Table 23. Human Rotavirus Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Human Rotavirus Vaccine Product Type
Table 25. Date of International Manufacturers Enter into Human Rotavirus Vaccine Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Human Rotavirus Vaccine Sales by Type (2015-2020) (K Units)
Table 28. Global Human Rotavirus Vaccine Sales Share by Type (2015-2020)
Table 29. Global Human Rotavirus Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Human Rotavirus Vaccine Revenue Share by Type (2015-2020)
Table 31. Human Rotavirus Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Human Rotavirus Vaccine Sales Share by Type (2021-2026)
Table 33. Global Human Rotavirus Vaccine Sales by Application (2015-2020) (K Units)
Table 34. Global Human Rotavirus Vaccine Sales Share by Application (2015-2020)
Table 35. Global Human Rotavirus Vaccine Sales Share by Application (2021-2026)
Table 36. Global Human Rotavirus Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 37. Global Human Rotavirus Vaccine Revenue by Application (2015-2020) (US$ Million)
Table 38. Global Human Rotavirus Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 39. United States Human Rotavirus Vaccine Sales (K Units) of Key Companies (2015-2020)
Table 40. United States Human Rotavirus Vaccine Sales Share by Company (2015-2020)
Table 41. United States Human Rotavirus Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 42. United States Human Rotavirus Vaccine Sales (K Units) by Type (2015-2020)
Table 43. United States Human Rotavirus Vaccine Sales Share by Type (2015-2020)
Table 44. United States Human Rotavirus Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 45. United States Human Rotavirus Vaccine Price (K Units) by Type (2015-2020)
Table 46. United States Human Rotavirus Vaccine Sales (K Units) by Type (2021-2026)
Table 47. United States Human Rotavirus Vaccine Sales Share by Type (2021-2026)
Table 48. United States Human Rotavirus Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 49. United States Human Rotavirus Vaccine Revenue Share by Type (2021-2026)
Table 50. United States Human Rotavirus Vaccine Price (K Units) by Type (2021-2026)
Table 51. United States Human Rotavirus Vaccine Sales (K Units) by Application (2015-2020)
Table 52. United States Human Rotavirus Vaccine Sales Share by Application (2015-2020)
Table 53. United States Human Rotavirus Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 54. United States Human Rotavirus Vaccine Sales (K Units) by Application (2021-2026)
Table 55. United States Human Rotavirus Vaccine Sales Share by Application (2021-2026)
Table 56. United States Human Rotavirus Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 57. United States Human Rotavirus Vaccine Revenue Share by Application (2021-2026)
Table 58. North America Human Rotavirus Vaccine Sales by Country (2015-2020) (K Units)
Table 59. North America Human Rotavirus Vaccine Sales Market Share by Country (2015-2020)
Table 60. North America Human Rotavirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 61. North America Human Rotavirus Vaccine Revenue Market Share by Country (2015-2020)
Table 62. Europe Human Rotavirus Vaccine Sales by Country (2015-2020) (K Units)
Table 63. Europe Human Rotavirus Vaccine Sales Market Share by Country (2015-2020)
Table 64. Europe Human Rotavirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 65. Europe Human Rotavirus Vaccine Revenue Market Share by Country (2015-2020)
Table 66. Asia Pacific Human Rotavirus Vaccine Sales by Region (2015-2020) (K Units)
Table 67. Asia Pacific Human Rotavirus Vaccine Sales Market Share by Region (2015-2020)
Table 68. Asia Pacific Human Rotavirus Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 69. Asia Pacific Human Rotavirus Vaccine Revenue Market Share by Region (2015-2020)
Table 70. Latin America Human Rotavirus Vaccine Sales by Country (2015-2020) (K Units)
Table 71. Latin America Human Rotavirus Vaccine Sales Market Share by Country (2015-2020)
Table 72. Latin Americaa Human Rotavirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 73. Latin America Human Rotavirus Vaccine Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Human Rotavirus Vaccine Sales by Country (2015-2020) (K Units)
Table 75. Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Country (2015-2020)
Table 76. Middle East and Africa Human Rotavirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 77. Middle East and Africa Human Rotavirus Vaccine Revenue Market Share by Country (2015-2020)
Table 78. Bharat Biotech Corporation Information
Table 79. Bharat Biotech Description and Business Overview
Table 80. Bharat Biotech Human Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Bharat Biotech Human Rotavirus Vaccine Product
Table 82. Bharat Biotech Recent Development
Table 83. Merck Corporation Information
Table 84. Merck Description and Business Overview
Table 85. Merck Human Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Merck Product
Table 87. Merck Recent Development
Table 88. GlaxoSmithKline Corporation Information
Table 89. GlaxoSmithKline Description and Business Overview
Table 90. GlaxoSmithKline Human Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. GlaxoSmithKline Product
Table 92. GlaxoSmithKline Recent Development
Table 93. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 94. Key Challenges
Table 95. Market Risks
Table 96. Main Points Interviewed from Key Human Rotavirus Vaccine Players
Table 97. Human Rotavirus Vaccine Customers List
Table 98. Human Rotavirus Vaccine Distributors List
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Rotavirus Vaccine Product Picture
Figure 2. Global Human Rotavirus Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Rotarix Product Picture
Figure 4. RotaTeq Product Picture
Figure 5. Rotavac Product Picture
Figure 6. Rotavin-M1 Product Picture
Figure 7. Lanzhou lamb Product Picture
Figure 8. Others Product Picture
Figure 9. Global Human Rotavirus Vaccine Sales Market Share by Application in 2020 & 2026
Figure 10. Hospitals & Clinics
Figure 11. Academic And Research
Figure 12. Others
Figure 13. Human Rotavirus Vaccine Report Years Considered
Figure 14. Global Human Rotavirus Vaccine Market Size 2015-2026 (US$ Million)
Figure 15. Global Human Rotavirus Vaccine Sales 2015-2026 (K Units)
Figure 16. Global Human Rotavirus Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Human Rotavirus Vaccine Sales Market Share by Region (2015-2020)
Figure 18. Global Human Rotavirus Vaccine Sales Market Share by Region in 2019
Figure 19. Global Human Rotavirus Vaccine Revenue Market Share by Region (2015-2020)
Figure 20. Global Human Rotavirus Vaccine Revenue Market Share by Region in 2019
Figure 21. Global Human Rotavirus Vaccine Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Human Rotavirus Vaccine Revenue in 2019
Figure 23. Human Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Human Rotavirus Vaccine Sales Market Share by Type (2015-2020)
Figure 25. Global Human Rotavirus Vaccine Sales Market Share by Type in 2019
Figure 26. Global Human Rotavirus Vaccine Revenue Market Share by Type (2015-2020)
Figure 27. Global Human Rotavirus Vaccine Revenue Market Share by Type in 2019
Figure 28. Global Human Rotavirus Vaccine Market Share by Price Range (2015-2020)
Figure 29. Global Human Rotavirus Vaccine Sales Market Share by Application (2015-2020)
Figure 30. Global Human Rotavirus Vaccine Sales Market Share by Application in 2019
Figure 31. Global Human Rotavirus Vaccine Revenue Market Share by Application (2015-2020)
Figure 32. Global Human Rotavirus Vaccine Revenue Market Share by Application in 2019
Figure 33. United States Human Rotavirus Vaccine Sales Growth Rate 2015-2026 (K Units)
Figure 34. United States Human Rotavirus Vaccine Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. United States Human Rotavirus Vaccine Market Share in Global Market 2015-2026
Figure 36. United States 5 and 10 Largest Human Rotavirus Vaccine Players Market Share by Revenue in Human Rotavirus Vaccine in 2019
Figure 37. United States Human Rotavirus Vaccine Revenue Share by Type (2015-2020)
Figure 38. United States Human Rotavirus Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 39. United States Human Rotavirus Vaccine Revenue Share by Application (2015-2020)
Figure 40. United States Human Rotavirus Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 41. North America Human Rotavirus Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 42. North America Human Rotavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America Human Rotavirus Vaccine Sales Market Share by Country in 2019
Figure 44. North America Human Rotavirus Vaccine Revenue Market Share by Country in 2019
Figure 45. U.S. Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 46. U.S. Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 48. Canada Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe Human Rotavirus Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 50. Europe Human Rotavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Human Rotavirus Vaccine Sales Market Share by Country in 2019
Figure 52. Europe Human Rotavirus Vaccine Revenue Market Share by Country in 2019
Figure 53. Germany Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 54. Germany Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 56. France Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 58. U.K. Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 60. Italy Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 62. Russia Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Asia Pacific Human Rotavirus Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 64. Asia Pacific Human Rotavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Human Rotavirus Vaccine Sales Market Share by Region in 2019
Figure 66. Asia Pacific Human Rotavirus Vaccine Revenue Market Share by Region in 2019
Figure 67. China Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 68. China Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 70. Japan Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 72. South Korea Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 74. India Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 76. Australia Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwan Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 78. Taiwan Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Indonesia Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 80. Indonesia Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Thailand Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 82. Thailand Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Malaysia Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 84. Malaysia Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Philippines Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 86. Philippines Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Vietnam Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 88. Vietnam Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Latin America Human Rotavirus Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 90. Latin America Human Rotavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Human Rotavirus Vaccine Sales Market Share by Country in 2019
Figure 92. Latin America Human Rotavirus Vaccine Revenue Market Share by Country in 2019
Figure 93. Mexico Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 94. Mexico Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 96. Brazil Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 98. Argentina Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Middle East and Africa Human Rotavirus Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 100. Middle East and Africa Human Rotavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Human Rotavirus Vaccine Revenue Market Share by Country in 2019
Figure 103. Turkey Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 104. Turkey Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 106. Saudi Arabia Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Human Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 108. U.A.E Human Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Porter's Five Forces Analysis
Figure 110. Human Rotavirus Vaccine Value Chain
Figure 111. Channels of Distribution
Figure 112. Distributors Profiles
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs